Pyxis Oncology PYXS Cash Flow Statement (2020-2026)

NASDAQ PYXS
$1.85 +0.09 (+5.11%)
As of: Oct 20, 2026 · 3:59 PM EDT
Reported Financials

Pyxis Oncology Quarterly Cash Flow Statement

Periods 23 quarters
Latest Jun 2026

Pyxis Oncology cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 23 quarters of results from Sep 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Net Income
-8.15M-14.18M-16.83M-31.38M-25.56M-27.67M-36.10M-19.24M-15.90M-23.05M-15.60M-3.26M-17.30M-21.20M-35.57M-21.16M-18.35M-22.00M-18.11M-25.35M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.22M0.16M0.16M0.16M0.16M0.20M0.19M0.19M0.52M0.52M0.69M1.12M0.59M0.73M0.55M0.55M0.54M0.53M2.90M
Share-based CompensationStock Comp.
0.55M0.31M3.11M3.40M2.82M3.16M3.90M4.88M3.67M5.18M3.22M4.32M2.87M2.98M2.77M3.63M3.02M3.07M2.08M5.53M
Gains from Investment SecuritiesGains Investment
-2.16M9.08M-12.05M
Other non-cash itemsOther Non-Cash
0.08M0.15M-3.21M0.23M0.32M0.31M9.55M0.14M0.18M0.15M0.19M0.16M0.17M0.18M0.19M0.19M0.20M0.21M0.22M
Change in Working Capital
Change in ReceivablesChange Receivables
8.00M
Change in Account PayablesChange Payables
0.08M0.97M4.03M-9.90M5.77M-2.31M-1.89M-0.75M-1.56M-1.54M0.35M-1.37M3.18M-0.60M-0.01M-2.01M6.57M0.34M1.13M
Change in Accured ExpensesChange Accured Exp.
0.38M3.28M1.93M10.54M-10.04M5.13M6.32M-13.27M2.13M0.71M-3.66M-2.14M-0.81M3.97M-2.69M-1.32M-3.36M1.30M0.55M
Change in Other Operating AssetsOther Assets Change
0.38M0.39M1.61M0.57M-1.27M1.03M3.05M-0.49M-0.19M-1.03M-0.82M2.05M-2.04M-1.26M1.46M0.93M1.57M-1.20M-1.57M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.15M-0.16M-0.16M-0.17M0.36M0.37M3.69M1.33M1.01M0.89M0.18M-8.21M-0.04M-0.31M-2.49M-0.34M-0.36M-0.37M-0.38M
Other Working Capital ChangesOther WC Changes
-0.53M-0.54M-1.77M-0.74M1.63M-0.66M0.64M1.82M1.20M1.92M1.00M-10.26M2.00M-0.02M-0.02M-1.27M-1.94M-0.02M-0.01M
Cash from OperationsCash from Ops.
2.86M-7.29M-12.17M-27.68M-23.71M-20.56M-17.39M-26.84M-11.03M-17.58M-15.25M-20.71M-3.01M-14.67M-19.29M-22.54M-17.26M-13.28M-10.43M
Investing Activities
Capital ExpendituresCapex
0.37M0.15M0.13M4.27M1.86M4.41M2.26M0.06M0.24M
Change in Property, Plant and EquipmentChange in PP&E
-0.37M-0.15M-0.13M-4.27M-1.86M-4.41M-2.26M-0.06M-0.24M
Acquisitions
0.00M
Net of Acquisitions & DivestmentsNet Acquisitions
0.00M
Purchase of InvestmentsInvestments Purchased
94.99M35.19M56.43M10.23M92.79M39.31M23.64M4.37M51.35M41.10M14.56M
Cash from Investing ActivitiesCash from Investing
-0.37M-0.15M-0.13M-4.27M-1.86M-99.39M-22.26M6.57M10.23M-18.50M0.00M-0.01M26.66M15.82M15.30M11.47M16.26M
Financing Activities
Change in Capital Stock
Common Stock IssuedStock Issued
152.45M0.18M0.00M0.01M0.22M0.03M47.12M0.15M0.07M0.05M0.00M0.74M
Net Shares Issued and RepurchasedNet Shares Issued
152.45M0.18M0.00M0.01M0.22M0.03M47.12M0.15M0.07M0.05M0.00M0.74M
Net Equity Issued and RepurchasedNet Equity Issued
152.45M0.18M0.00M0.01M0.22M0.03M47.12M0.15M0.07M0.05M0.00M0.74M
Other financing activitiesOther financing
-0.68M-1.72M-0.05M-0.20M-0.04M0.00M0.00M-0.07M-0.01M-0.07M
Cash from Financing ActivitiesCash from Financing
-0.68M-1.71M154.90M0.18M0.00M0.01M-0.17M-0.03M57.51M0.11M1.66M0.05M-0.01M0.67M
Additional items
Change in Cash
1.81M-9.00M142.73M-27.65M-23.84M-24.82M-19.25M-126.23M-27.16M-11.18M-5.05M18.30M-2.89M-13.02M7.42M-6.71M-2.03M-1.81M6.50M
Ending Cash Balance
142.58M133.59M276.32M248.67M224.83M200.01M180.77M54.53M27.37M16.19M11.14M29.44M26.55M13.53M20.95M14.23M12.21M10.39M16.89M20.33M
Free Cash FlowFCF
2.49M-7.29M-12.17M-27.83M-23.84M-24.82M-19.25M-31.25M-13.29M-17.64M-15.25M-20.95M-3.01M-14.67M-19.29M-22.54M-17.26M-13.28M-10.43M
Net Cash FlowNCF
1.81M-9.00M142.73M-27.65M-23.84M-24.82M-19.25M-126.23M-33.29M-11.18M-5.05M18.30M-2.89M-13.02M7.42M-6.71M-1.96M-1.81M6.50M
Income Taxes PaidTaxes Paid
0.02M0.03M

Pyxis Oncology Cash Flow Statement API

Pull Pyxis Oncology's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=PYXS&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY